Early research (Phase 1)Study completedNCT00104923
What this trial is testing
Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+1 more
California Cancer Consortium 29